Phenotypic cardiotoxicity screening with human 3D heart tissues
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN271201500033C
- Awardee
-
Invivosciences, Inc. UEI G5JDXMW3NSW3
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $225,000
Award facts
- Opportunity
-
- PHS20151 Solicitation number
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (sbir) contract proposals Award Notice · Posted Jul 31, 2014
- Contract value 100% obligated
- $225,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 8 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53719, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Original award | $225,000 |
About this award
The U.S. National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services (HHS), awarded a $225,000.00 Firm Fixed Price Definitive Contract to Invivosciences, Inc., a small disadvantaged business, for "PHENOTYPIC CARDIOTOXICITY SCREENING WITH HUMAN 3D HEART TISSUES". This award is set aside for total small business participation. Invivosciences provides research and development services in the field of medical science, with a focus on cardiac physiology analysis, high-resolution image analysis, and the development of adult stem cell treatments. The contract supports the agency's efforts to advance translational science and develop new medical treatments.
Quick answers
Who was awarded contract HHSN271201500033C?
HHSN271201500033C was awarded to Invivosciences, Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on June 15, 2015.
How much is contract HHSN271201500033C worth?
The government has obligated $225,000 on HHSN271201500033C.
Was contract HHSN271201500033C competed?
The extent of competition for HHSN271201500033C was full and open competition after exclusion of sources. The government received 8 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award